ORION OYJ
Last · Helsinki€83.10+0.50 (+0.61%)stale · yahoo · 43h ago
Market cap€11.7B109.0M sh
P/E · TTM20.7fwd 17.6 · eps 4.02
Beta0.28vs S&P 500
Div yield2.18%annual · TTM
52w range
€56.50€84.60
Volume25.4Ksession
Loading chart…
Upcoming earnings
4:30 PM UTC+1
Period
Sep 2026
Est. EPS
$1.08
Est. revenue
533.0M
Earnings transcripts
- Issuer webcast
7/3/2026 Orion publishes Half-Year Report for January–June 2026 and holds a webcast on 17 July 2026
ORION OYJ
- Issuer webcast
7/3/2026 Orion publishes Half-Year Report for January–June 2026 and holds a webcast on 17 July 2026
Orion Oyj
- Issuer webcast
Q3 2018 webcast
ORION OYJ
- Issuer webcast
Q2 2012 webcast
ORION OYJ
- Issuer webcast
Q3 2010 webcast
ORION OYJ
- Issuer webcast
Q1 2025 webcast
ORION OYJ
Press & signals
- GlobeNewswire
125,000 Orion Corporation A shares converted into B shares
- GlobeNewswire
Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market
- GlobeNewswire
Orion Pharma announces first patient dosed in Phase 1/2 clinical trial of ODM-216, the company’s first biologic candidate to reach clinical testing
The rest of this company's wire — with summaries and source links — is part of Pro.
See plansDocuments
FormReporting forFiledFlags